Sep 4, 2025 07:56AM Maxim Group Upgrades Dare Bioscience (DARE) to Buy, PT $8

Aug 18, 2025 03:59PM Dare Bioscience (DARE) PT Lowered to $11 at Brookline Capital Markets

Aug 14, 2025 04:48PM Dare Bioscience (DARE) Misses Q2 EPS by 45c

Jul 15, 2025 07:16AM H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)

Jul 14, 2025 08:03AM Daré Bioscience reports interim Phase 3 results for hormone-free contraceptive

Jul 11, 2025 08:00AM Daré Bioscience receives $6 million grant installment for contraception device

Jun 5, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)

Jun 4, 2025 08:01AM Dare Bioscience (DARE) and Rosy Wellness Announce Strategic Collaboration to Educate and Market Daré’s DARE to PLAY Sildenafil Cream

May 13, 2025 07:04PM Dare Bioscience (DARE) Misses Q1 EPS by 50c

Feb 20, 2025 08:04AM Daré Bioscience (DARE) and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant

Feb 6, 2025 08:02AM Dare Bioscience (DARE) Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development

Dec 16, 2024 08:04AM Dare Bioscience (DARE) Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder

Dec 4, 2024 08:04AM Dare Bioscience (DARE) Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Nov 14, 2024 05:32PM Dare Bioscience (DARE) Misses Q3 EPS by 55c

Nov 13, 2024 08:07AM Dare Bioscience (DARE) Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene Pivotal Study Clinical Trial Sites

Oct 24, 2024 07:45AM H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)

Oct 23, 2024 12:34PM Dare Bioscience (DARE) Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

Oct 21, 2024 08:05AM Dare Bioscience (DARE) Announces $15M Common Stock Purchase Agreement with Lincoln Park Capital Fund

Aug 26, 2024 08:03AM Dare Bioscience (DARE) Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Aug 13, 2024 08:19AM Dare Bioscience (DARE) Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Jul 24, 2024 11:00PM These stocks offer you exposure to rising demand for fertility treatment – Barclays

Jul 19, 2024 08:00AM Dare Bioscience (DARE) Regains Nasdaq Compliance

Jul 1, 2024 06:54AM Biotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals' Board of Directors

Jun 27, 2024 08:04AM Dare Bioscience (DARE) Announces 1:12 Reverse Share Split